BRIEF published on 04/14/2026 at 09:05, 4 months 29 days ago MVISE AG Sets Bold Buy & Build Strategy Strategic Investment Software Acquisition Germany Market MVISE AG Buy & Build
PRESS RELEASE published on 04/14/2026 at 09:00, 4 months 29 days ago Original-Research: mVISE AG (von NuWays AG): BUY mVISE AG announces negotiations to acquire minority stakes in three software-centric companies, signaling transformation into a Buy & Build platform. Potential for market leadership and revenue growth Acquisition Market Leadership MVISE AG Software-centric Companies Buy & Build Platform
BRIEF published on 04/13/2026 at 09:51, 5 months ago MVISE AG Negotiates Three Strategic Investments Germany Investments Software Companies Market Leadership MVISE AG
PRESS RELEASE published on 04/13/2026 at 09:46, 5 months ago mVISE AG is in concrete negotiations regarding three investments mVISE AG in concrete negotiations for investments in three software-focused companies, aiming for German market leadership positions. Operational performance targets include annual EBITDA of EUR 1-1.5 million Negotiations Investments MVISE AG Software-focused Companies German Market Leadership
BRIEF published on 04/01/2026 at 13:34, 5 months 11 days ago MVISE AG Extends Convertible Bond to 2030 Investors Financial Performance Extension Convertible Bond MVISE AG
PRESS RELEASE published on 04/01/2026 at 13:29, 5 months 11 days ago mVISE AG successfully extends its 22/26 convertible bond until 2030 mVISE AG extends 22/26 convertible bond to 2030, aligning debt and equity interests. Bond terms amended with attractive 4.50% coupon for investors Convertible Bond Debt Equity Interests MVISE AG Amended Bond Terms
BRIEF published on 02/10/2026 at 09:05, 7 months 3 days ago MVISE AG Reports Strong Profitability Amid Strategic Sales Decline Profitability Software Development Recurring Revenues MVISE AG Strategic Sales Decline
PRESS RELEASE published on 02/10/2026 at 09:00, 7 months 3 days ago Original-Research: mVISE AG (von NuWays AG): BUY mVISE AG's strong profitability despite lower sales base in FY25. Strategic shift towards software-centric development models positively impacting recurring sales and EBITDA margins. Management guidance for FY26 looks achievable Sales Profitability Software Development MVISE AG FY25
BRIEF published on 02/09/2026 at 09:31, 7 months 4 days ago MVISE AG Reports Strong Performance Despite Market Challenges in 2025 Software Development Strategic Transformation EBITDA Growth MVISE AG 2025 Financials
PRESS RELEASE published on 02/09/2026 at 09:26, 7 months 4 days ago mVISE AG announces preliminary figures for 2025 mVISE AG announces strong financial results for 2025, with EBITDA up 15% to EUR 1.3 million, recurring customer revenue at 70%, and reduction of long-term liabilities by EUR 750 thousand Financial Results EBITDA Recurring Revenue MVISE AG Long-term Liabilities
Published on 09/12/2026 at 02:35, 1 day 7 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 11 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 12 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 17 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 16 hours 17 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 2 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 11 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 11 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 14 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 3 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 14 hours ago Availability of the 2026 Interim Financial Report
